New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Accrufer ferric maltol Click here for more information |
Shield TX | An oral iron replacement product for iron deficiency in adults. |
|
Balversa erdafitinib Click here for more information |
Janssen | A kinase inhibitor for advanced or metastatic urothelial cancer. |
|
Cablivi caplacizumab-yhdp Click here for more information |
Ablynx U.S. | A von Willebrand factor-directed antibody fragment for treatment of acquired thrombotic thrombocytopenic purpura (aTTP). |
|
Egaten triclabendazole Click here for more information |
Novartis | An oral anthelmintic for treatment of fascioliasis. |
|
Eticovo etanercept-ykro Click here for more information |
Samsung Bioepis | A biosimilar to Enbrel. |
|
Evenity romosozumab-aqqg Click here for more information |
Amgen | A sclerostin inhibitor for treatment of postmenopausal osteoporosis in patients at high risk for fracture. |
|
Hadlima adalimumab-bwwd Click here for more information |
Merck | A biosimilar to Humira. |
|
Herceptin Hylecta trastuzumab/hyaluronidase-oysk Click here for more information |
Genentech | A subcutaneous injection formulation for HER2-overexpressing breast cancer. |
|
Jeuveau prabotulinumtoxin A-xvfs |
Evolus | A botulinum toxin product to improve the appearance of frown lines between the eyebrows. |
|
Kanjinti trastuzumab-anns Click here for more information |
Amgen | A biosimilar to Herceptin. |
|
Mayzent siponimod Click here for more information |
Novartis | An oral tablet formulation for relapsing forms of multiple sclerosis. |
|
Nubeqa darolutamide Click here for more information |
Bayer | An oral androgen receptor inhibitor for non-metastatic castration-resistant prostate cancer. |
|
Ontruzant trastuzumab-dttb |
Merck | A biosimilar to Herceptin for breast cancer and gastric/gastroesophageal junction cancer. |
|
Piqray alpelisib Click here for more information |
Novartis | A kinase inhibitor for advanced or metastatic breast cancer. |
|
Polivy polatuzumab vedotin-piiq Click here for more information |
Genentech | A monoclonal antibody for relapsed or refractory diffuse large B-cell lymphoma. |
|
Recarbrio imipenem/cilastatin/relebactam Click here for more information |
Merck | A combination antibiotic, renal dehydropeptidase inhibitor, and beta-lactamase inhibitor for complicated UTIs or intra-abdominal infections. |
|
Ruxience rituximab-pvvr Click here for more information |
Pfizer | A biosimilar to Rituxan. |
|
Skyrizi risankizumab-rzaa Click here for more information |
AbbVie | An interleukin-23 antagonist for moderate to severe plaque psoriasis. |
|
Spravato esketamine Click here for more information |
Janssen | An NMDA receptor antagonist nasal spray for treatment-resistant depression. |
|
Sunosi solriamfetol Click here for more information |
Jazz Pharm. | A dopamine and norepinephrine reuptake inhibitor (DNRI) for excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. |
|
Trazimera trastuzumab-qyyp Click here for more information |
Pfizer | A biosimilar to Herceptin for breast cancer and gastric/gastroesophageal junction cancer. |
|
Turalio pexidartinib Click here for more information |
Daiichi Sankyo | An oral kinase inhibitor for symptomatic tenosynovial giant cell tumor. |
|
Vyleesi bremelanotide Click here for more information |
AMAG Pharm. | A melanocortin receptor agonist for premenopausal women with hypoactive sexual desire disorder. |
|
Vyndamax tafamidis Click here for more information |
Pfizer | A transthyretin stabilizer for cardiomyopathy in certain patients with amyloidosis. |
|
Vyndaqel tafamidis meglumine Click here for more information |
Pfizer | A transthyretin stabilizer for cardiomyopathy in certain patients with amyloidosis. |
|
Xpovio selinexor Click here for more information |
Karyopharm Therapeutics | A nuclear export inhibitor for patients with relapsed or refractory multiple myeloma. |
|
Zirabev bevacizumab-bvzr Click here for more information |
Pfizer | A biosimilar to Avastin. |
|
Zulresso brexanolone Click here for more information |
Sage Therapeutics | An injectable medication for treatment of postpartum depression. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Adhansia XR methylphenidate Click here for more information |
Purdue Pharma | New extended-release formulation for ADHD. |
|
Avaclyr acyclovir |
Fera Pharm. | An ophthalmic ointment for acute herpetic keratitis. |
|
Baqsimi glucagon Click here for more information |
Lilly | A new nasal powder formulation for severe hypoglycemia. |
|
Dovato dolutegravir/lamivudine |
ViiV Healthcare | New combination formulation for HIV-1 infection. |
|
Drizalma Sprinkle duloxetine delayed-release Click here for more information |
Sun Pharm. | A new sprinkle formulation SNRI. |
|
Duaklir Pressair aclidinium/formoterol Click here for more information |
AstraZeneca | A combination anticholinergic and long-acting beta-agonist oral inhaler for COPD. |
|
Duobrii halobetasol propionate/tazarotene Click here for more information |
Bausch Health | New combination topical steroid/retinol lotion for plaque psoriasis. |
|
Gloperba colchicine Click here for more information |
Romeg Therapeutics | A new oral solution formulation for prevention of gout flares in adults. |
|
Jatenzo testosterone undecanoate Click here for more information |
Clarus Therapeutics | An oral androgen for testosterone replacement therapy. |
|
Katerzia amlodipine Click here for more information |
Silvergate Pharm. | A new oral suspension formulation calcium channel blocker. |
|
Lotemax SM loteprednol etabonate Click here for more information |
Bausch + Lomb | New 0.38% steroid ophthalmic gel formulation to improve absorption. For post-op inflammation/pain following ocular surgery. |
|
Mavenclad cladribine Click here for more information |
EMD Serono | New tablet formulation for treatment of relapsing forms of multiple sclerosis. |
|
Myxredlin insulin Click here for more information |
Celerity Pharm. | Short-acting human insulin in sodium chloride for intravenous use. |
|
Nayzilam midazolam Click here for more information |
Proximagen | New benzodiazepine nasal spray formulation for acute treatment of intermittent episodes of frequent seizure activity in patients with epilepsy. |
|
Qternmet XR dapagliflozin/saxagliptin/metformin Click here for more information |
AstraZeneca | New combination product for type 2 diabetes. |
|
Rocklatan netarsudil/latanoprost Click here for more information |
Aerie Pharm. | New combination Rho kinase inhibitor and prostaglandin analogue to reduce intraocular pressure. |
|
Ruzurgi amifampridine Click here for more information |
Jacobus | New formulation for children with Lambert-Eaton myasthenic syndrome. |
|
Slynd drospirenone Click here for more information |
Exeltis | New progestin-only formulation to prevent pregnancy. |
|
Thiola EC tiopronin Click here for more information |
Mission Pharmacal | New delayed-release formulation for prevention of cystine stone formation in patients with severe homozygous cystinuria. |
|
Tosymra sumatriptan Click here for more information |
Promius Pharma | New 10 mg nasal spray formulation for acute migraine. |
|
Zykadia ceritinib Click here for more information |
Novartis | New tablet formulation for metastatic non-small cell lung cancer. |
| Brand/Generic | Company | Description |
|---|